115 related articles for article (PubMed ID: 29387415)
1. Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma.
Erturk K; Tas F; Serilmez M; Bilgin E; Duranyildiz D
Mol Clin Oncol; 2018 Jan; 8(1):204-208. PubMed ID: 29387415
[TBL] [Abstract][Full Text] [Related]
2. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer.
Afsar CU; Karabulut M; Karabulut S; Ozal ST; Cikot M; Serilmez M; Tas F
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30544746
[TBL] [Abstract][Full Text] [Related]
4. High neural precursor cell-expressed developmentally down-regulated 9 expression is a poor prognostic indicator for osteosarcoma.
Feng J; Gu Y; Zhou L; Rui G; Liu W
Transl Cancer Res; 2020 Nov; 9(11):7196-7204. PubMed ID: 35117323
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of NEDD9 in renal cell carcinoma is associated with tumor migration and invasion.
Wang J; Wang S; Luan Y; Zhang W; Sun C; Cheng G; Li K; Xin Q; Lin Z; Qi T; Kong F
Oncol Lett; 2017 Dec; 14(6):8021-8027. PubMed ID: 29344245
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma.
Harb OA; Haggag R; Ali MM; El Shorbagy S; Abdelbary AM; Abdelaziz LA; Salim RA; Abdel Wahab KM
J Oncol; 2017; 2017():6095205. PubMed ID: 28194179
[No Abstract] [Full Text] [Related]
7. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
[TBL] [Abstract][Full Text] [Related]
8. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
[TBL] [Abstract][Full Text] [Related]
9. Roles of neural precursor cell expressed, developmentally downregulated 9 in tumor-associated cellular processes (Review).
Zhang S; Wu L
Mol Med Rep; 2015 Nov; 12(5):6415-21. PubMed ID: 26324022
[TBL] [Abstract][Full Text] [Related]
10. Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.
Semelakova M; Grauzam S; Betadthunga P; Tiedeken J; Coaxum S; Neskey DM; Rosenzweig SA
Transl Oncol; 2019 Jan; 12(1):49-61. PubMed ID: 30267961
[TBL] [Abstract][Full Text] [Related]
11. NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT.
Meng H; Wu J; Huang Q; Yang X; Yang K; Qiu Y; Ren J; Shen R; Qi H
Oncol Lett; 2019 Oct; 18(4):4022-4029. PubMed ID: 31516604
[TBL] [Abstract][Full Text] [Related]
12. NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis.
Gu Y; Lu J; Chen C; Zheng F
Onco Targets Ther; 2019; 12():4213-4222. PubMed ID: 31213839
[No Abstract] [Full Text] [Related]
13. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
Radulović P; Krušlin B
Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases.
Jurčić P; Radulović P; Balja MP; Milošević M; Krušlin B
Oncol Lett; 2019 Mar; 17(3):2881-2889. PubMed ID: 30854064
[TBL] [Abstract][Full Text] [Related]
15. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7.
Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S
Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675
[TBL] [Abstract][Full Text] [Related]
16. Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients.
Erturk K; Tas F; Serilmez M; Bilgin E; Yasasever V
Asian Pac J Cancer Prev; 2017 May; 18(5):1383-1387. PubMed ID: 28612591
[TBL] [Abstract][Full Text] [Related]
17. The role of neural precursor cell-expressed developmentally down-regulated protein 9 in predicting bacillus Calmette-Guerin response in nonmuscle invasive bladder cancer.
El-Babouly IM; Desoky EAE; El Sayed D; Ali MM; Harb OA; Ragab A; Sakr AM; Fawzi AM; Salama NM; Samaha II
Urol Oncol; 2018 May; 36(5):242.e9-242.e14. PubMed ID: 29519561
[TBL] [Abstract][Full Text] [Related]
18. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma.
Zhou S; Xu M; Shen J; Liu X; Chen M; Cai X
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):677-686. PubMed ID: 28578938
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a eukaryotic expression vector for small interfering RNA targeting the NEDD9 gene.
Chang JX; Wang HQ; Zhao GQ; Chu HY; Zhang GJ
Int J Mol Med; 2012 Dec; 30(6):1343-8. PubMed ID: 23007337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
